EXACT Sciences Corporation

Exact Sciences is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Stool-based DNA (sDNA) technology is included in the colorectal cancer screening guidelines of the American Cancer Society and the U.S. Multi-Society Task Force on Colorectal Cancer.
Type
Public
HQ
Madison, US
Founded
1995
Size (employees)
736 (est)+9%
EXACT Sciences Corporation was founded in 1995 and is headquartered in Madison, US

EXACT Sciences Corporation Office Locations

EXACT Sciences Corporation has an office in Madison
Madison, US (HQ)
441 Charmany Dr

EXACT Sciences Corporation Metrics

EXACT Sciences Corporation Financial Metrics

Revenue (2016)

$99.4 m

Revenue growth (2015-16), %

152%

Gross profit

$54.2 m

Gross profit margin (2016), %

55%

Net income (2016)

($167.2 m)

Market capitalization (21-Mar-2017)

$2.4 b

Closing share price (21-Mar-2017)

$21.2

Cash (31-Dec-2016)

$48.9 m
EXACT Sciences Corporation's current market capitalization is $2.4 b.
EXACT Sciences Corporation's revenue was reported to be $99.4 m in FY, 2016 which is a 152% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$4.1 m$1.8 m$39.4 m$99.4 m

Revenue growth, %

(57%)2093%152%

Cost of goods sold

$4.3 m$24.5 m$45.2 m

Gross profit

($2.5 m)$14.9 m$54.2 m

Gross profit Margin, %

(141%)38%55%

Operating expense total

$50.9 m$98 m$174 m$223.2 m

EBIT

($46.8 m)($100.5 m)($159.1 m)($169 m)

EBIT margin, %

(1128%)(5592%)(403%)(170%)

Interest expense

$69 k$51 k$6 k$213 k

Net Income

($46.5 m)($100 m)($157.8 m)($167.2 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$12.9 m$58.1 m$41.1 m$48.9 m

Accounts Receivable

$1.4 m$8.5 m

Inventories

$2.2 m$3.5 m$7.6 m$7.1 m

Current Assets

$135.5 m$291.7 m$326.1 m$333.6 m

PP&E

$11.2 m

Total Assets

$146.6 m$311.6 m$364.3 m$377 m

Accounts Payable

$761 k$2.6 m$3.3 m$710 k

Current Liabilities

$7.8 m$17.5 m$26.7 m$30.7 m

Additional Paid-in Capital

$455.2 m$709 m$904.9 m$1.1 b

Retained Earnings

($320.8 m)($420.8 m)($578.6 m)($745.8 m)

Total Equity

$135.3 m$289 m$326.9 m$335.3 m

Financial Leverage

1.1 x1.1 x1.1 x1.1 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($46.5 m)($100 m)($157.8 m)($167.2 m)

Accounts Receivable

($1.4 m)($3.6 m)$8.5 m

Inventories

($1.6 m)($1.3 m)($3.1 m)$7.1 m

Accounts Payable

($2.9 m)$1.9 m$661 k$710 k

Cash From Operating Activities

($39.3 m)($80.9 m)($134 m)

Purchases of PP&E

($9.3 m)($12.5 m)($20.1 m)

Cash From Investing Activities

($35.5 m)($117.8 m)($64.8 m)

Cash From Financing Activities

$74.3 m$244 m$181.8 m

Interest Paid

$95 k

EXACT Sciences Corporation Market Value History

EXACT Sciences Corporation Online Presence

EXACT Sciences Corporation Company Life

You may also be interested in